Michael Bonney, CEO, Director at Cubist Pharma, holds 0.00 shares in Cubist Pharma (Ticker: CBST), holds 0.00 shares in Global Blood Therapeutics (Ticker: GBT), holds 9.13K shares in Sarepta Therapeutics (Ticker: SRPT).
Michael Bonney latest transaction was an Uninformative Sell of $18.73M.
What was Michael Bonney's most profitable transaction?
Michael Bonney’s most profitable transaction was an Informative Buy of SRPT stock on September 9, 2019. The return on the trade was 50.60%.
What is Michael Bonney's role in Cubist Pharma?
Michael Bonney's role in Cubist Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.